Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · IEX Real-Time Price · USD
2.10
+0.35 (20.00%)
At close:
May 31, 2023, 4:00 PM
2.01
-0.09 (-4.29%)
After-hours:
May 31, 2023, 6:50 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General & Admin | 12.7 | 13.13 | 10.05 | 6.06 | 7.24 | 11.1 | 1.94 | 12.62 | 8.89 | 3.55 | |
| Research & Development | 27.08 | 23.74 | 6.13 | 8.13 | 6.82 | 2.02 | 3.19 | 32.64 | 14.58 | 12.2 | |
| Other Operating Expenses | 48.65 | 0 | 2.28 | 1.87 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Operating Expenses | 88.43 | 36.87 | 18.47 | 16.05 | 14.06 | 13.12 | 5.13 | 45.26 | 23.46 | 15.75 | |
| Operating Income | -88.43 | -36.87 | -18.47 | -16.05 | -14.06 | -13.12 | -5.13 | -45.26 | -23.46 | -15.75 | |
| Other Expense / Income | -0.46 | -0.01 | 4.75 | -0.04 | 0.01 | -0.01 | 0.53 | -0.17 | -0.17 | -0.02 | |
| Pretax Income | -87.97 | -36.86 | -23.22 | -16.01 | -14.07 | -13.12 | -5.66 | -45.09 | -23.3 | -15.73 | |
| Income Tax | 0 | -2.35 | -0.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Income | -87.97 | -34.51 | -22.81 | -16.01 | -14.07 | -13.12 | -5.66 | -45.09 | -23.3 | -15.73 | |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.09 | |
| Net Income Common | -87.97 | -34.51 | -22.81 | -16.01 | -14.07 | -13.12 | -5.66 | -45.09 | -23.3 | -15.82 | |
| Shares Outstanding (Basic) | 14 | 15 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 14 | 15 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |
| Shares Change | -3.61% | 921.03% | 121.41% | 31.03% | 92.52% | 1122.10% | -84.68% | 247.55% | 1455.06% | 33.54% | |
| EPS (Basic) | -6.16 | -2.33 | -15.72 | -24.42 | -28.08 | -41.40 | -44.28 | -325.62 | -583.20 | -6159.25 | |
| EPS (Diluted) | -6.16 | -2.33 | -15.72 | -24.42 | -28.08 | -41.40 | -44.28 | -325.62 | -583.20 | -6159.25 | |
| Free Cash Flow Per Share | -1.99 | -1.95 | -10.48 | -21.14 | -23.77 | -57.46 | -231.47 | -301.18 | -529.53 | -6035.14 | |
| EBITDA | -87.59 | -36.67 | -23.03 | -15.83 | -14.05 | -13.09 | -5.62 | -44.98 | -23.28 | -15.72 | |
| Depreciation & Amortization | 0.37 | 0.2 | 0.18 | 0.18 | 0.01 | 0.02 | 0.04 | 0.11 | 0.02 | 0.01 | |
| EBIT | -87.97 | -36.86 | -23.22 | -16.01 | -14.07 | -13.12 | -5.66 | -45.09 | -23.3 | -15.73 |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).